GlassScriptPhysician profile
Ingrid M Mcclain
NPI 1366420127
$1,558.85
in general payments reported to CMS, 2019-2025
8 companies · $1,170 in 2025
The $1,170 reported for 2025 was more than what 93% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $173 · 2020: $12.90 · 2022: $63.68 · 2023: $64.74 · 2024: $75.24 · 2025: $1,170.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $907 · Food and Beverage: $402.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $907.14 |
| Food and Beverage | $402.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $1,272.60 | 2019-2025 | Misight Contact Lens, Myday Contact Lens, Clariti Contact Lens |
| Shire North American Group INC | $121.13 | 2019 | |
| Alcon Vision LLC | $68.70 | 2022-2024 | Total30 |
| Johnson & Johnson Vision Care, INC. | $40.14 | 2019 | |
| Abbvie INC. | $15.51 | 2022 | |
| Lkc Technologies, INC. | $14.71 | 2024 | |
| Tarsus Pharmaceuticals, INC. | $14.13 | 2024 | Xdemvy |
| Allergan, INC. | $11.93 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ingrid Mcclain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.